Forest Laboratories, Inc. announced today that an Office Action in the Reexamination of U.S. Patent No. 6,545,040 ("the '040 patent") was received from the U.S. Patent and Trademark Office ("USPTO") by Janssen Pharmaceutica N.V., the patent holder of the '040 patent.
The details can be read here.
No comments:
Post a Comment